Results 121 to 130 of about 745 (163)

Selected Pharmacological Studies of an Alkaloidal Extract of Banisteriopsis Quitensis

Journal of Pharmaceutical Sciences, 1971
The preparation and pharmacological testing of an alkaloidal extract of Banisteriopsis quitensisare presented. The extract was found to exert numerous effects on the CNS in mice, including sedation, transient paralysis, ataxia, prolongation of hexobarbital “sleeping” times, and prevention of reserpine‐induced hypothermia.
R E, Stull, N M, Ferguson, G G, Ferguson
exaly   +3 more sources

Action of Alkaloidal Extract of Banisteriopsis quitensis on Rabbit Ileum

Journal of Pharmaceutical Sciences, 1972
An alkaloidal extract of Banisteriopsis quitensis (Niedenzu) Morton was tested using a rabbit ileum preparation, and inhibition of contractions was noted in untreated strips as well as in those treated with most known stimulants of strip motility. This action was additive with the effect of agents that inhibit strip motility.
exaly   +3 more sources

Shihunine and Dihydroshihunine From Banisteriopsis caapi

Journal of Natural Products, 1982
Kazuko Kawanishi
exaly   +2 more sources

BANISTERIOPSIS

1991
exaly   +2 more sources

The Alkaloid of Banisteriopsis Inebrians Morton

Journal of the American Pharmaceutical Association (Scientific ed.), 1953
The stems of Banisteriopsis inebrians were found to contain 0.15 per cent of the alkaloid harmine, but the other alkaloids that accomany harmine in peganum harmala could not be detected. The leaves were found to contain an alkaloid which was partly identified as harmine.
F D, O'CONNELL, E V, LYNN
openaire   +2 more sources

New alkaloids from Banisteriopsis caapi

Phytochemistry, 1976
Abstract Three new alkaloids isolated from Banisteriopsis caapi , were identified as harmic amide (1-carbamoyl-7-methoxy β-carboline), acetyl norharmine (1-acetyl-7-methoxy β-carboline) and ketotetrahydronorharmine (7-methoxy-1,2,3,4-tetrahydro-1-oxo-β-carboline)
Yohei Hashimoto, Kazuko Kawanishi
openaire   +1 more source

Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism

Pharmacology Biochemistry and Behavior, 2003
Dopamine deficiency is characteristic of Parkinson's disease (PD) and treatments aim at elevating levels by administration of its precursor L-dihydroxyphenylalanine (L-DOPA), or inhibiting monoamine oxidases (MAOs), thus preventing its breakdown. Reports of improvements in PD patients treated with Banisteriopsis caapi extracts stimulated investigation ...
Schwarz, M J, Houghton, P J, Rose, S, Jenner, P, Lees, A D   +4 more
openaire   +3 more sources

Phytochemical Analyses ofBanisteriopsis CaapiandPsychotria Viridis

Journal of Psychoactive Drugs, 2005
A total of 32 Banisteriopsis caapi samples and 36 samples of Psychotria viridis were carefully collected from different plants on the same day from 22 sites throughout Brazil for phytochemical analyses. A broad range in alkaloid distribution was observed in both sample sets. All B.
J C, Callaway, Glacus S, Brito, Edison S, Neves   +2 more
openaire   +2 more sources